The Interpretation and Utility of Thoracic Ultrasound in the Evaluation of Pneumothorax in a Critically Ill Patient: Case Report and Literature Review

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 72A
Author(s):  
Bassel Ericsoussi ◽  
Michael A. Markos ◽  
Ruxana T. Sadikot ◽  
Mehmet S. Ozcan
2019 ◽  
Vol 45 (3) ◽  
pp. 570-572
Author(s):  
Stefania Capra ◽  
Sujita W. Narayan ◽  
Kaitlyn Parratt ◽  
Asad E. Patanwala

2020 ◽  
Vol 2 (11) ◽  
pp. 2445-2447
Author(s):  
Heidi Angela Fernandez ◽  
Martín Lescano Ruiz ◽  
Stephanie González Jara

2019 ◽  
Vol 1 (8) ◽  
pp. 633-636
Author(s):  
Enrico Bentivegna ◽  
Ludovica Guerritore ◽  
Piera Amoriello L. ◽  
Valerio Spuntarelli ◽  
Alberto Sentimentale ◽  
...  

Author(s):  
Andrew Alalade ◽  
Christopher Millward ◽  
Piyali Pal ◽  
Catherine Gilkes

Author(s):  
Carlos Rubiano ◽  
Kathleen Tompkins ◽  
Subhashini A Sellers ◽  
Brian Bramson ◽  
Joseph Eron ◽  
...  

Abstract We present a case of a critically ill patient with COVID-19 found to have AIDS and Pneumocystis jirovecii pneumonia (PCP). COVID-19 and PCP co-occurrence is increasingly reported and may complicate diagnostic and therapeutic strategies. Patients with severe COVID-19 should be screened for underlying immunocompromise and coinfections should be considered.


2021 ◽  
pp. 194187442110043
Author(s):  
Henly Hewan ◽  
Annie Yang ◽  
Aparna Vaddiparti ◽  
Benison Keung

In late 2019, the novel coronavirus, SARS-CoV-2, and the disease it causes, COVID-19, was identified. Since then many different neurological manifestations of COVID-19 have been well reported. Movement abnormalities have been rarely described. We report here a critically ill patient with COVID-19 who developed generalized myoclonus during the recovery phase of the infection. Myoclonus was associated with cyclical fevers and decreased alertness. Movements were refractory to conventional anti-epileptic therapies. There was concern that myoclonus could be part of a post-infectious immune-mediated syndrome. The patient improved fully with a 4-day course of high-dose steroids. Our experience highlights a rare, generalized myoclonus syndrome associated with COVID-19 that may be immune-mediated and is responsive to treatment.


Sign in / Sign up

Export Citation Format

Share Document